Skip to main content

Lifevantage Corp

LFVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000849146

In the last 90 days, Lifevantage Corp insiders filed 1 open-market purchase and 1 sale; 88 institutions reported holding it in 13F filings for Q2 2026, worth $36.9M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Lifevantage Corp changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of LFVN: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders8376−7
Shares7.03M5.38M−1.65M (−23.4%)
Value$65.7M$39.5M−$26.2M (−39.8%)

New holders (14)

Institutions that held Lifevantage Corp at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to LFVN in Q2 2021
InstitutionSharesValue% of portfolio
Millennium Management LLC249,609$1.83M0.00%
Ergoteles LLC62,000$456.0K0.01%
Tibra Equities Europe Ltd48,300$355.0K0.11%
HRT Financial LP38,000$279.0K0.00%
Jane Street Group, LLC21,136$155.0K0.00%
ExodusPoint Capital Management, LP18,397$135.0K0.00%
D. E. Shaw & Co., Inc.17,022$125.0K0.00%
Two Sigma Advisers, LP16,300$120.0K0.00%
Trexquant Investment LP14,516$107.0K0.01%
Campbell & CO Investment Adviser LLC13,500$99.0K0.04%
Susquehanna International Group, LLP11,804$87.0K0.00%
New England Professional Planning Group Inc.10,000$75.0K0.05%
AE Wealth Management LLC10,116$74.0K0.00%
Advisory Services Network, LLC4,220$31.0K0.00%

Sold out (21)

Institutions that held Lifevantage Corp at the end of Q1 2021 and filed for Q2 2021 without it.